Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Tiziana Life Sciences has announced that the last patient in its Phase 2a INFORM-MS trial of intranasal foralumab for non-active Secondary Progressive Multiple Sclerosis (na-SPMS) has been dosed. This randomized, double-blind, placebo-controlled study is evaluating safety, tolerability, and efficacy of the drug in up to 48 patients across multiple …
GDS Holdings Limited held its 2026 Annual General Meeting where all shareholder resolutions were approved, including the re-election and election of directors, extension of the equity incentive plan, appointment of auditors, and authorization to issue new shares up to 30% of existing share capital. Leadership changes included the departure of long-…
Highlander Silver Corp. reported results from a detailed geophysical program at its Corani Silver Project, revealing a significantly larger mineral system concealed beneath shallow cover. The company identified several high-priority exploration targets and has commenced the first drilling program in over a decade, with initial assays expected soon.…
Seres Therapeutics announced an upcoming webcast to present top-line data from an investigator-sponsored trial evaluating their live biotherapeutic SER-155 for immune checkpoint inhibitor-related enterocolitis (irEC), a severe side effect of cancer immunotherapy. The trial, conducted at Memorial Sloan Kettering Cancer Center, aims to show SER-155's…
Montauk Brewing Co., a craft beer brand under Tilray Brands, Inc., marks its 14th anniversary with a special celebration at its Brew Barn in Montauk, NY. Events include the release of a limited Jalapeño Watermelon Ale, a community beach cleanup, a surfboard raffle benefiting the Surfrider Foundation, local food offerings, and live summer soccer cov…
INmune Bio Inc. announced that the UK Medicines & Healthcare products Regulatory Agency (MHRA) approved the Pediatric Investigation Plan (PIP) for Ebstrocel™, part of the CORDStrom™ platform, targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB). This regulatory milestone accelerates the path toward Marketing Authorization in the UK, aligning…
Winnebago Industries announced its third quarter fiscal 2026 results with net revenues of $698.7 million, down 9.9% year-over-year driven by lower unit volumes, despite growth in the Motorhome RV segment. Adjusted EPS declined to $0.66 from $0.81 the prior year, reflecting industry headwinds including elevated fuel costs and weak consumer confidenc…
Lightbridge Corporation announced the successful removal of the first batch of its fuel material samples from irradiation testing at INL's Advanced Test Reactor. The samples will now undergo post-irradiation examination, providing critical data to support Lightbridge's nuclear fuel performance modeling, regulatory licensing, and commercial deployme…
Satellos Bioscience Inc. announced new data from its SAT-3247 clinical development program will be featured at the 19th International Congress on Neuromuscular Diseases (ICNMD). The data includes six-month follow-up results from Phase 1b participants and ongoing Phase 2 trial updates. SAT-3247 is an investigational oral therapy aimed at regeneratin…
Baker Hughes has been awarded a contract by Azule Energy to supply advanced subsea production systems, including deepwater horizontal tree systems and control modules, to support efficient oil production in Angola's ultra-deepwater Greater PAJ development. The company will leverage its local Angolan facilities and supply chain to optimize installat…
Kymera Therapeutics announced early completion of enrollment in its Phase 2b BROADEN2 clinical trial for KT-621, an oral STAT6 degrader targeting moderate to severe atopic dermatitis. This accelerated enrollment allows for topline data readout by year-end 2026, six months ahead of schedule, and plans to initiate Phase 3 trials by mid-2027. KT-621 i…
Atea Pharmaceuticals has completed patient enrollment in its Phase 3 C-FORWARD trial evaluating the bemnifosbuvir and ruzasvir combination for hepatitis C treatment outside North America. This milestone advances Atea's global clinical program alongside the ongoing North American C-BEYOND trial, with topline results expected around year-end 2026, po…
Autolus Therapeutics plc announced its participation in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference, with CEO Dr. Christian Itin presenting a Fireside Chat to discuss the company's next-generation programmed T cell therapies. The event webcast will be accessible online and archived for 90 days.
Micron crushed Q3 results and raised guidance, signaling durable AI and data-center demand. The stock is expensive on standard multiples but the combination of multi-year customer contracts, material free cash flow, and low leverage justifies a directional long trade. Entry at $1,200, stop at $1,000, and target at $1,500 over a 45-trading-day swing…
Booking Holdings faces headlines about AI cutting out intermediaries. The more likely outcome is a shifting cost mix and incremental product improvements, not wholesale disintermediation. At $181.27 the stock offers a reasonable entry: attractive free cash flow, positive technical momentum and valuation that already prices in some growth concerns. …
Documents reviewed by Reuters show Morgan Stanley provided one of the earliest pieces of institutional capital to entities controlled by Paresh Raja, the founder of Market Financial Solutions Ltd. The investment - a £50 million purchase of Class A loan notes in November 2021 from Earthave Bridging - preceded a wider set of bank exposures that left …
Barclays has reaffirmed equities as its preferred asset class for the third quarter, arguing that an AI-driven U.S. earnings cycle should offset concerns about currently stretched valuations. The bank raised its 2026 S&P 500 EPS forecast and price target, highlighted favored sectors tied to AI investment, flagged Japan as a compelling non-U.S. expo…
The International Monetary Fund projects Switzerland's economic expansion will weaken in the short term, slowing to 1.1% in 2026 from 1.4% in 2025, before picking up to 1.2% in 2027. Adjustments for scheduled sporting events lower the 2026 growth estimate to 0.8% and raise the 2027 figure to 1.5%. The IMF also expects full-year inflation to run at …
Deutsche Bank has upgraded Vonovia SE from hold to buy and raised its price target to €26 from €25, adding the German landlord to a trio of sector top picks that includes Merlin Properties and VGP. Analyst Thomas Rothaeusler cites trough valuation and priced-in rate expectations as reasons for upside potential, even as the bank adopts a cautious ma…
HydroGraph Clean Pwr (HGRAF) is an OTC-listed speculative play on graphene-enabled clean-power technologies. The stock is deeply oversold, trading under key moving averages, and carries very high short interest. For disciplined traders willing to accept high execution and dilution risk, a small starter long with a defined stop and long-term target …
McCormick & Company reported quarterly results that exceeded analyst estimates, with adjusted EPS of $0.80 and revenue of $1.94 billion. The company reiterated its fiscal 2026 adjusted EPS guidance and expects full-year net sales growth driven in part by the McCormick de Mexico acquisition. Improved gross margins were supported by the acquisition, …
Eni SpA shares fell 1.8% to trade at €20.415 during the session as a drop in crude oil benchmarks, with the WTI August futures around $69.5 per barrel, pressured oil-sector stocks on Piazza Affari. No company-specific news was found to explain the decline, which follows a substantial retracement from a 52-week high hit in early April 2026.
On June 25 McCormick reported second-quarter revenue and adjusted earnings above Wall Street expectations, citing sustained consumer demand for spices and seasonings as households cook more at home amid economic uncertainty. The company also reiterated progress on its proposed roughly $45 billion merger with Unilever’s food business, a deal that wo…
Darden Restaurants shares fell about 2.1% in pre-market trading as investors positioned for the company’s fiscal fourth-quarter 2026 results. Street expectations call for adjusted EPS near $3.63–$3.64 and revenue of $3.73 billion. Concerns centered on Olive Garden same-store sales, where one analyst modeled results below consensus, while LongHorn S…
Schaeffler shares climbed after Citi characterized the stock as a buying opportunity, citing a near-trough valuation for the core business and potential additional value from non-automotive initiatives. The move came amid improving operating margins reported in Q1 2026 and a broader constructive trading backdrop for German equities.
